{"id":2282,"date":"2023-07-04T08:09:00","date_gmt":"2023-07-04T08:09:00","guid":{"rendered":"https:\/\/dailyai.com\/?p=2282"},"modified":"2023-07-05T08:09:37","modified_gmt":"2023-07-05T08:09:37","slug":"first-ai-generated-drug-given-go-ahead-for-human-trials","status":"publish","type":"post","link":"https:\/\/dailyai.com\/nl\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","title":{"rendered":"Eerste AI-gegenereerde medicijn groen licht voor proeven op mensen"},"content":{"rendered":"<p><strong>Insilico Medicine heeft goedkeuring gekregen voor proeven op mensen met hun volledig door AI gegenereerde medicijn.<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Het geneesmiddel is ontwikkeld als mogelijke behandeling voor idiopathische longfibrose (IPF), een degeneratieve ziekte die littekenvorming en verdikking van het longweefsel veroorzaakt. IPF treft alleen al in de VS ongeveer 100.000 mensen. Het nieuwe geneesmiddel, INS018_055 genaamd, zal gedurende 12 weken worden getest in China en er zijn uitgebreide tests gepland in China en de VS.<\/span><\/p>\n<p><a href=\"https:\/\/insilico.com\/\"><span style=\"font-weight: 400;\">Insilico<\/span><\/a><span style=\"font-weight: 400;\"> is een biotechbedrijf uit Hong Kong dat AI gebruikt voor de ontwikkeling van nieuwe medicijnen en voor onderzoek tegen veroudering. De toepassing van AI in hun onderzoek heeft gezorgd voor een veel snellere ontwikkeling van nieuwe medicijnen.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\"AI stelt ons in staat om enorme hoeveelheden gegevens te analyseren en verbanden te vinden die menselijke wetenschappers misschien over het hoofd zien, om vervolgens geheel nieuwe moleculen te 'bedenken' die kunnen worden omgezet in geneesmiddelen\", aldus Alex Zhavoronkov, oprichter en CEO van Insilico Medicine.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Het bedrijf gebruikt AI in elke stap van zijn strategie voor medicijnontwikkeling. Eerst gebruiken ze hun AI-tool, PandaOmics genaamd, om een \"doelwit\" of biologische oorzaak te identificeren die gekoppeld is aan een specifieke ziekte. Het doelwit kan bijvoorbeeld een gen of eiwit zijn dat niet goed functioneert.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Zodra ze een doelwit hebben ge\u00efdentificeerd, gebruiken ze hun andere AI-platform, Chemistry42, om een molecuul te ontwerpen dat het probleem oplost door het doelwit te blokkeren zonder de pati\u00ebnt schade te berokkenen.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In dit geval verwijst de \"55\" in de naam van het geneesmiddel naar de 55e molecule die werd ontworpen en veelbelovend bleek.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">De Fase II studies die zijn goedgekeurd zijn bedoeld om te zien of het medicijn een significante respons geeft bij de eerste deelnemers. Als dit succesvol is, gaat het naar Fase III studies om de veiligheid en effectiviteit te bevestigen voordat de FDA goedkeuring kan geven.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Insilico Medicine heeft een aantal interessante AI-geneesmiddelontwikkelingen in de pijplijn. De FDA heeft onlangs de eerste aanvraag voor een investigational new drug (IND) goedgekeurd voor hun geneesmiddel tegen kanker dat zich richt op solide tumoren. Fase I-proeven zijn gepland voor juli 2023 in de VS en China.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Als we horen over generatieve AI denken we normaal gesproken aan afbeeldingen, liedjes of tekst die wordt gegenereerd. Maar Insilico gebruikt generatieve AI om de doelwitten te identificeren die een ziekte veroorzaken en vervolgens moleculen te ontwerpen die deze doelwitten direct aanpakken.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Als je ChatGPT zou vragen op welke eiwitten men zich zou kunnen richten om een specifieke vorm van borstkanker te behandelen, zou het deze eiwitten kunnen identificeren omdat het toegang heeft tot gepubliceerd medisch onderzoek. Insilico heeft zijn eigen LLM, ChatPandaGPT genaamd, waarmee onderzoekers zoekopdrachten in natuurlijke taal kunnen gebruiken om een gespecialiseerde kennisbank van grote hoeveelheden klinische gegevens te doorzoeken.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Gebruik <\/span><a href=\"https:\/\/dailyai.com\/nl\/2023\/06\/researchers-create-high-performance-ai-model-to-detect-heart-disease-from-ecgs\/\"><span style=\"font-weight: 400;\">AI in de geneeskunde<\/span><\/a><span style=\"font-weight: 400;\"> helpt bedrijven als Insilico om het ontdekkingsproces van medicijnen drastisch te verkorten. Hun <\/span><a href=\"https:\/\/insilico.com\/pipeline\"><span style=\"font-weight: 400;\">onderzoekspijplijn<\/span><\/a><span style=\"font-weight: 400;\"> heeft een opwindende reeks van potenti\u00eble behandelingen voor verschillende soorten kanker, evenals een COVID-19 medicijn dat ook in Fase I testen zit.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Insilico Medicine heeft goedkeuring gekregen voor proeven op mensen met hun volledig door AI gegenereerde medicijn. Het medicijn is ontworpen als mogelijke behandeling voor idiopathische longfibrose (IPF), een degeneratieve ziekte die littekenvorming en verdikking van het longweefsel veroorzaakt. IPF treft alleen al in de VS ongeveer 100.000 mensen. Het nieuwe geneesmiddel, INS018_055 genaamd, zal gedurende 12 weken worden getest in China en er zijn uitgebreide tests gepland in China en de VS. Insilico is een in Hong Kong gevestigd biotechbedrijf dat AI gebruikt voor het ontwikkelen van nieuwe medicijnen en voor anti-verouderingsonderzoek. De toepassing van AI in hun<\/p>","protected":false},"author":6,"featured_media":2283,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[84],"tags":[150,107,101],"class_list":["post-2282","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry","tag-ai-benefits","tag-generative-ai","tag-medtech"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>First AI-generated drug given go-ahead for human trials | DailyAI<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dailyai.com\/nl\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First AI-generated drug given go-ahead for human trials | DailyAI\" \/>\n<meta property=\"og:description\" content=\"Insilico Medicine has been given approval for human trials of their completely AI-generated drug. The drug has been designed as a potential treatment for idiopathic pulmonary fibrosis (IPF) which is a degenerative disease that causes scarring and thickening of the lung tissues. IPF affects around 100,000 people in the US alone. The new drug, called INS018_055, will be trialed for 12 weeks in China with expanded trials planned for China and the US. Insilico is a Hong Kong based biotech company that uses AI to develop new medicines as well as in anti-aging research. The application of AI in their\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dailyai.com\/nl\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"DailyAI\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-04T08:09:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-05T08:09:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"563\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Eugene van der Watt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:site\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"Eugene van der Watt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\"},\"author\":{\"name\":\"Eugene van der Watt\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/7ce525c6d0c79838b7cc7cde96993cfa\"},\"headline\":\"First AI-generated drug given go-ahead for human trials\",\"datePublished\":\"2023-07-04T08:09:00+00:00\",\"dateModified\":\"2023-07-05T08:09:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\"},\"wordCount\":479,\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"keywords\":[\"AI benefits\",\"Generative AI\",\"MedTech\"],\"articleSection\":[\"Industry\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\",\"name\":\"First AI-generated drug given go-ahead for human trials | DailyAI\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"datePublished\":\"2023-07-04T08:09:00+00:00\",\"dateModified\":\"2023-07-05T08:09:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"width\":1000,\"height\":563,\"caption\":\"AI generated drug gets human trial approval\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dailyai.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First AI-generated drug given go-ahead for human trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"name\":\"DailyAI\",\"description\":\"Your Daily Dose of AI News\",\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dailyai.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\",\"name\":\"DailyAI\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"width\":4501,\"height\":934,\"caption\":\"DailyAI\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/DailyAIOfficial\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/dailyaiofficial\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@DailyAIOfficial\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/7ce525c6d0c79838b7cc7cde96993cfa\",\"name\":\"Eugene van der Watt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"caption\":\"Eugene van der Watt\"},\"description\":\"Eugene comes from an electronic engineering background and loves all things tech. When he takes a break from consuming AI news you'll find him at the snooker table.\",\"sameAs\":[\"www.linkedin.com\\\/in\\\/eugene-van-der-watt-16828119\"],\"url\":\"https:\\\/\\\/dailyai.com\\\/nl\\\/author\\\/eugene\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eerste AI-gegenereerde medicijn krijgt groen licht voor proeven op mensen | DailyAI","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dailyai.com\/nl\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","og_locale":"nl_NL","og_type":"article","og_title":"First AI-generated drug given go-ahead for human trials | DailyAI","og_description":"Insilico Medicine has been given approval for human trials of their completely AI-generated drug. The drug has been designed as a potential treatment for idiopathic pulmonary fibrosis (IPF) which is a degenerative disease that causes scarring and thickening of the lung tissues. IPF affects around 100,000 people in the US alone. The new drug, called INS018_055, will be trialed for 12 weeks in China with expanded trials planned for China and the US. Insilico is a Hong Kong based biotech company that uses AI to develop new medicines as well as in anti-aging research. The application of AI in their","og_url":"https:\/\/dailyai.com\/nl\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","og_site_name":"DailyAI","article_published_time":"2023-07-04T08:09:00+00:00","article_modified_time":"2023-07-05T08:09:37+00:00","og_image":[{"width":1000,"height":563,"url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","type":"image\/jpeg"}],"author":"Eugene van der Watt","twitter_card":"summary_large_image","twitter_creator":"@DailyAIOfficial","twitter_site":"@DailyAIOfficial","twitter_misc":{"Geschreven door":"Eugene van der Watt","Geschatte leestijd":"3 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#article","isPartOf":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/"},"author":{"name":"Eugene van der Watt","@id":"https:\/\/dailyai.com\/#\/schema\/person\/7ce525c6d0c79838b7cc7cde96993cfa"},"headline":"First AI-generated drug given go-ahead for human trials","datePublished":"2023-07-04T08:09:00+00:00","dateModified":"2023-07-05T08:09:37+00:00","mainEntityOfPage":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/"},"wordCount":479,"publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"image":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","keywords":["AI benefits","Generative AI","MedTech"],"articleSection":["Industry"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","url":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","name":"Eerste AI-gegenereerde medicijn krijgt groen licht voor proeven op mensen | DailyAI","isPartOf":{"@id":"https:\/\/dailyai.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage"},"image":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","datePublished":"2023-07-04T08:09:00+00:00","dateModified":"2023-07-05T08:09:37+00:00","breadcrumb":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","width":1000,"height":563,"caption":"AI generated drug gets human trial approval"},{"@type":"BreadcrumbList","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dailyai.com\/"},{"@type":"ListItem","position":2,"name":"First AI-generated drug given go-ahead for human trials"}]},{"@type":"WebSite","@id":"https:\/\/dailyai.com\/#website","url":"https:\/\/dailyai.com\/","name":"DailyAI","description":"Uw dagelijkse dosis AI-nieuws","publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dailyai.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/dailyai.com\/#organization","name":"DailyAI","url":"https:\/\/dailyai.com\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","width":4501,"height":934,"caption":"DailyAI"},"image":{"@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/DailyAIOfficial","https:\/\/www.linkedin.com\/company\/dailyaiofficial\/","https:\/\/www.youtube.com\/@DailyAIOfficial"]},{"@type":"Person","@id":"https:\/\/dailyai.com\/#\/schema\/person\/7ce525c6d0c79838b7cc7cde96993cfa","name":"Eugene van der Watt","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","caption":"Eugene van der Watt"},"description":"Eugene heeft een achtergrond in elektrotechniek en houdt van alles wat met techniek te maken heeft. Als hij even pauzeert van het consumeren van AI-nieuws, kun je hem aan de snookertafel vinden.","sameAs":["www.linkedin.com\/in\/eugene-van-der-watt-16828119"],"url":"https:\/\/dailyai.com\/nl\/author\/eugene\/"}]}},"_links":{"self":[{"href":"https:\/\/dailyai.com\/nl\/wp-json\/wp\/v2\/posts\/2282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailyai.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyai.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyai.com\/nl\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyai.com\/nl\/wp-json\/wp\/v2\/comments?post=2282"}],"version-history":[{"count":1,"href":"https:\/\/dailyai.com\/nl\/wp-json\/wp\/v2\/posts\/2282\/revisions"}],"predecessor-version":[{"id":2284,"href":"https:\/\/dailyai.com\/nl\/wp-json\/wp\/v2\/posts\/2282\/revisions\/2284"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyai.com\/nl\/wp-json\/wp\/v2\/media\/2283"}],"wp:attachment":[{"href":"https:\/\/dailyai.com\/nl\/wp-json\/wp\/v2\/media?parent=2282"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyai.com\/nl\/wp-json\/wp\/v2\/categories?post=2282"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyai.com\/nl\/wp-json\/wp\/v2\/tags?post=2282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}